Janssen Search
Search results
Tom Heyman
Tom Heyman is the Global Head of Business Development, Pharmaceuticals Group of Janssen Global Services, LLC. In this role, he is responsible for all of the licensing and acquisition activities in this group. The Johnson & Johnson Development ...
Profiles in Scientific Courage: The First Cancer Cures
Profiles in Scientific Courage: The First Cancer Cures It Takes More Than Just Science During this pandemic year, our sense of urgency in the biomedical research community has been sharpened and tested. In oncology research, I believe that this is a time ...
Lack of evidence to support use of darunavir-based treatments for SARS-CoV-2
Lack of evidence to support use of darunavir-based treatments for SARS-CoV-2 Mar 16, 2020 Anecdotal, unsubstantiated reports claim that darunavir has antiviral effect against COVID-19 Johnson & Johnson has no evidence that darunavir has any effect ...
Clinical Trials Other Projects
R&D Operations Innovation Is Exploring Initiatives to Improve Patient-Centered Clinical Trials Janssen Research & Development Operations Innovation is dedicated to developing new strategies and solutions to improve the clinical trial experience ...
Partnerships for Fighting and Preventing Infectious Disease
Article Type: Infectious Diseases & Vaccines Partner with Janssen in Infectious Diseases & Vaccines Infectious diseases are one of the greatest threats to mankind, evolving, spreading and disproportionately affecting the most vulnerable. Through ...
Gert Scheper, Ph.D.
As the Oral Cavity & Oropharyngeal Cancer/Cervical Cancer Venture Leader for the Disease Interception Accelerator (DIA), Gert is responsible for leading efforts focused on these diseases within the DIA, creating solutions that will enable the ...
Meet a Researcher Who's Spent Much of Her Career Fighting Prostate Cancer
Fighting Prostate Cancer Margaret Yu, M.D., Vice President, Disease Area Leader, Prostate Cancer, in her Janssen lab. There’s promising news in the fight against prostate cancer: According to a recent study conducted by the American Cancer Society, ...
Measuring and Maintaining Health
Measuring and Maintaining Health Our research starts with healthy people and explores health rather than disease. We search for prevention markers, which are biological measures of health status and risk. Prevention markers will direct our future search ...
The Importance of Studying the Broad Impact of Psoriatic Arthritis
The Importance of Studying the Broad Impact of Psoriatic Arthritis In my work at Janssen Immunology supporting clinical development of medicines for patients with psoriatic arthritis (PsA), I get an opportunity to think a lot about how these patients’ ...
ACR 2020 Newsroom
Welcome to the Janssen Immunology ACR 2020 Newsroom! Below, please find the latest for our meeting news, a message from our leaders, social feeds, and more information about our progress and commitment to developing innovative medicines for rheumatologic ...